Jeffrey Silva, Director of Product Development, Adeptrix Corporation discusses BAMS™ Assay Platform

2 views

|

January 26, 2021

Jeffrey explained how BAMS™ Assay Platform simplifies the process for targeted- and discovery-based proteomic applications, by replacing the need for liquidchromatography separation methods in the analysis of complex biological samples by utilizing affinity enrichment (e.g. antibody-based) directed to specific target proteins, prior to MS analysis.

Analytical TechniquesMass SpectrometryProteomics and Metabolomics

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.